SYNPO2L Activators are a diverse group of compounds that enhance the functional activity of SYNPO2L through various biochemical mechanisms primarily affecting the cytoskeletal dynamics. Phorbol 12-myristate 13-acetate (PMA) and Bisindolylmaleimide I both modulate the activity of protein kinase C, with PMA directly activating PKC and potentially leading to SYNPO2L phosphorylation, thus enhancing its cytoskeletal interactions, while Bisindolylmaleimide I, a PKC inhibitor, can paradoxically prevent PKC overactivation, thereby maintaining SYNPO2L in an optimally active phosphorylated state. Forskolin and 8-Bromo-cAMP, by raising intracellular cAMP levels, activate protein kinase A, which can phosphorylate SYNPO2L and promote its binding to actin, a key component of the cytoskeleton. Ionomycin, by increasing intracellular calcium, may activate calmodulin-dependent kinases, subsequently enhancing SYNPO2L function in the cytoskeleton.Similarly, Cytochalasin D and Jasplakinolide act directly on the actin cytoskeleton, with Cytochalasin D disrupting polymerization and potentially triggering compensatory mechanisms that activate SYNPO2L, and Jasplakinolide stabilizing actin filaments, thereby potentially enhancing the actin-binding activity of SYNPO2L. Additionally, Calyculin A and Okadaic acid, both inhibitors of protein phosphatases, could sustain SYNPO2L activity by preventing dephosphorylation, a modification crucial for its functional role within the cytoskeleton. Epigallocatechin gallate (EGCG) may also contribute by inhibiting kinases that phosphorylate proteins interacting with SYNPO2L, indirectly enhancing its function.
Lithium chloride's inhibition of glycogen synthase kinase 3 (GSK-3) could lead to enhanced activity of SYNPO2L by modulating the phosphorylation status of proteins within its functional network. Anisomycin, by activating stress-activated protein kinases (SAPKs), could also enhance SYNPO2L activity through stress-induced phosphorylation events that impact cytoskeletal organization. Collectively, these activators work through intricate cellular pathways that converge on the regulation of phosphorylation and cytoskeletal dynamics, ultimately leading to the enhancement of SYNPO2L's role in maintaining the structural integrity of cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to phosphorylation of SYNPO2L, enhancing its actin-binding and bundling activity involved in cytoskeletal organization. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels and thereby activating PKA. PKA can phosphorylate SYNPO2L, which may enhance its interaction with other cytoskeletal proteins. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to the phosphorylation and functional enhancement of SYNPO2L, promoting its role in cytoskeletal reorganization. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK). CaMK activation can potentially enhance the activity of SYNPO2L by promoting its association with cytoskeletal elements. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins. This inhibition could result in the sustained activation of SYNPO2L through increased phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases and might enhance SYNPO2L activity by altering the phosphorylation status of proteins that interact with SYNPO2L, modulating its function in the cytoskeleton. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that, paradoxically, can enhance PKC substrates' activity by preventing PKC overactivation. This could indirectly maintain SYNPO2L in a functionally active state. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and prevents their depolymerization. Stabilized actin could enhance the actin-binding function of SYNPO2L, promoting its role in maintaining cytoskeletal architecture. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization. The consequent changes in cytoskeletal dynamics could lead to compensatory mechanisms that enhance the activity of SYNPO2L in actin organization. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to an increase in protein phosphorylation. This could enhance SYNPO2L activity by maintaining it in a hyperphosphorylated state that promotes its cytoskeletal functions. | ||||||